Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr;26(3-4):163-183.
doi: 10.1007/s10495-021-01661-5. Epub 2021 Mar 9.

New insights into targeting mitochondria in ischemic injury

Affiliations
Review

New insights into targeting mitochondria in ischemic injury

Jingjing Jia et al. Apoptosis. 2021 Apr.

Abstract

Stroke is the leading cause of adult disability and death worldwide. Mitochondrial dysfunction has been recognized as a marker of neuronal death during ischemic stroke. Maintaining the function of mitochondria is important for improving the survival of neurons and maintaining neuronal function. Damaged mitochondria induce neuronal cell apoptosis by releasing reactive oxygen species (ROS) and pro-apoptotic factors. Mitochondrial fission and fusion processes and mitophagy are of great importance to mitochondrial quality control. This paper reviews the dynamic changes in mitochondria, the roles of mitochondria in different cell types, and related signaling pathways in ischemic stroke. This review describes in detail the role of mitochondria in the process of neuronal injury and protection in cerebral ischemia, and integrates neuroprotective drugs targeting mitochondria in recent years, which may provide a theoretical basis for the progress of treatment of ischemic stroke. The potential of mitochondrial-targeted therapy is also emphasized, which provides valuable insights for clinical research.

Keywords: Ischemic stroke; Mitochondria; Mitochondrial dynamics; Mitophagy; Neuroprotective drugs; Reactive oxygen species.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Adibhatla RM, Hatcher JF (2008) Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies. CNS Neurol Disord Drug Targets 7(3):243–253. https://doi.org/10.2174/187152708784936608 - DOI - PubMed - PMC
    1. Henninger N, Fisher M (2016) Extending the Time Window for Endovascular and Pharmacological Reperfusion. Transl Stroke Res 7(4):284–293. https://doi.org/10.1007/s12975-015-0444-4 - DOI - PubMed
    1. Wang X, Asahi M, Lo EH (1999) Tissue type plasminogen activator amplifies hemoglobin-induced neurotoxicity in rat neuronal cultures. Neurosci Lett 274(2):79–82. https://doi.org/10.1016/s0304-3940(99)00682-5 - DOI - PubMed
    1. Segura T, Calleja S, Jordan J (2008) Recommendations and treatment strategies for the management of acute ischemic stroke. Expert Opin Pharmacother 9(7):1071–1085. https://doi.org/10.1517/14656566.9.7.1071 - DOI - PubMed
    1. Andrabi SS, Parvez S, Tabassum H (2020) Ischemic stroke and mitochondria: mechanisms and targets. Protoplasma 257(2):335–343. https://doi.org/10.1007/s00709-019-01439-2 - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources